Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eugene Kim

Plastic Surgery Orange, CA Medical Doctor

NPI 1780864504 CMS profile 307828

200 S Manchester Ave, Suite 650, Orange, CA 92868

Open in the dashboard

General payments

$6,132

242 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eugene Kim of Orange, CA is reported in the CMS Open Payments database as having received $6,132 across 242 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $250 10
2024 General $629 31
2023 General $613 28
2022 General $1,481 54
2021 General $1,273 50
2020 General $623 34
2019 General $1,263 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eugene Kim
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Eugene Kim were reported at $250. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Eugene Kim Plastic Surgery median Middle half National median
2019 $1,263 $371 $122–$1,483 $163
2020 $623 $158 $52–$438 $114
2021 $1,273 $249 $87–$752 $132
2022 $1,481 $274 $102–$793 $149
2023 $613 $299 $113–$891 $160
2024 $629 $361 $124–$1,062 $164
2025 $250 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Mentor Worldwide LLC $3,358 140 payments
  2. Sientra, Inc. $1,181 16 payments
  3. Allergan Inc. $1,009 53 payments
  4. AbbVie, Inc. $320 18 payments
  5. Galderma Laboratories, L.P. $264 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,132 242 payments
Products named General payments · program years 2019–2025
  1. MENTOR MemoryGel Resterilizable Gel Sizer $2,871 120 payments
  2. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $1,181 16 payments
  3. NATRELLE $624 33 payments
  4. MemoryGel Breast Implants $487 20 payments
  5. BOTOX $232 14 payments
  6. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $160 9 payments
  7. BOTOX COSMETIC $89 4 payments
  8. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $63 3 payments
  9. ARTOURA Breast Tissue Expander $35 1 payment
  10. DYSPORT $20 1 payment
  11. Other $19 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

242 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record